P709: CLINICAL OUTCOME OF ASCIMINIB TREATMENT IN A REAL-WORLD MULTI-RESISTANT CML PATIENT POPULATION.

• C. C. Kockerols,
• J. J. Janssen,
• N. M. Blijlevens,
• S. K. Klein,
• L. G. van Hussen-Daenen,
• G. N. van Gorkom,
• W. M. Smit,
• P. van Balen,
• B. J. Biemond,
• M. J. Cruijsen,
• M. F. Corsten,
• P. A. te Boekhorst,
• H. R. Koene,
• G. L. van Sluis,
• J. J. Cornelissen,
• P. E. Westerweel

Affiliations

C. C. Kockerols

1 Internal Medicine, Albert Schweitzer Hospital, Dordrecht

J. J. Janssen

2 Hematology, Amsterdam University Medical Center, location VUMC, Amsterdam

N. M. Blijlevens

3 Hematology, Radboud University Medical Center, Nijmegen

S. K. Klein

4 Hematology, University Medical Center Groningen, Groningen

L. G. van Hussen-Daenen

5 Hematology, University Medical Center Utrecht, Utrecht

G. N. van Gorkom

6 Hematology, Maastricht University Medical Center, Maastricht

W. M. Smit

7 Hematology, Medisch Spectrum Twente, Enschede

P. van Balen

8 Hematology, Leiden University Medical Center, Leiden

B. J. Biemond

9 Hematology, Amsterdam University Medical Center, location AMC, Amsterdam

M. J. Cruijsen

10 Hematology, Catharina Hospital, Eindhoven

M. F. Corsten

11 Hematology, Meander Medical Center, Amersfoort

P. A. te Boekhorst

12 Hematology, Erasmus University Medical Center, Rotterdam

H. R. Koene

13 Hematology, St.-Antonius Hospital, Nieuwegein

G. L. van Sluis

14 Hematology, Isala, Zwolle, Netherlands

J. J. Cornelissen

12 Hematology, Erasmus University Medical Center, Rotterdam

P. E. Westerweel

1 Internal Medicine, Albert Schweitzer Hospital, Dordrecht